FOXF2 and skin neoplasm: FREAC2 (FOXF2) targets are downregulated across the development sequence (Supplementary Fig. 6g), and although it has not been specifically implicated in skin cancer, downregulation of its expression promotes epithelial–mesenchymal transition in basal breast cancer51.